Immunovia's IPO

Immunovia raised a round of funding on April 04, 2018. Investors include Public.

Immunovia develops a platform called IMMray, based on antibody microarray analysis. The company also performs clinical validation studies for commercialization.…

Articles about Immunovia's IPO: